Search

Your search keyword '"Toprak, Umut H."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Toprak, Umut H." Remove constraint Author: "Toprak, Umut H." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
29 results on '"Toprak, Umut H."'

Search Results

1. Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)

3. The genomic and transcriptional landscape of primary central nervous system lymphoma

4. Altered enhancer-promoter interaction leads to MNX1expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)

5. Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome

6. Altered enhancer-promoter interaction leads toMNX1expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)

7. S120: MNX1-ACTIVATING ENHANCER HIJACKING EVENTS IN ACUTE MYELOID LEUKEMIA WITH DELETIONS ON CHROMOSOME 7Q

8. Supplementary Patient Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

9. Supplementary Table S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

10. Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

11. Supplementary Figure S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer

12. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

13. Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas

14. Combined burden and functional impact tests for cancer driver discovery using DriverPower

15. Integrative pathway enrichment analysis of multivariate omics data

16. Pathway and network analysis of more than 2500 whole cancer genomes

17. Divergent mutational processes distinguish hypoxic and normoxic tumours

18. Genomic footprints of activated telomere maintenance mechanisms in cancer

19. Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia

20. Comprehensive genomic characterization of refractory multiple myeloma reveals a complex mutational and structural landscape associated with drug resistance [Abstract]

21. T-cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level

22. Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia

23. Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas

24. T‐cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level

25. Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities

26. Loss of p16INK4a in neuroblastoma cells induces shift to an immature state with mesenchymal characteristics and increases sensitivity to EGFR inhibitors

27. FOXR2 Stabilizes MYCN Protein and Identifies Non–MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome

29. Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas.

Catalog

Books, media, physical & digital resources